Type to search

Chris Torrance

Share
Chris Torrance
CEO
PhoreMost

Chris Torrance

‘PhoreMost Therapeutics’ is a Start-up Biotech company that aims to ‘drug the undruggable’

We are launching a phenotypic screening platform that is able to reveal cryptic druggable sites in specific targets/pathways in a live-cell context and then de-orphan these targets with functional lead-molecules for partnering with Pharma

Posts Featuring Chris Torrance


Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: addcslashes() expects parameter 1 to be string, array given in /home/customer/www/pharmtechfocus.com/public_html/wp-includes/class-wpdb.php on line 1562
PhoreMost Expands into New Facility at Unity Campus, Cambridge, UK | Pharmtech Focus

PhoreMost Expands into New Facility at Unity Campus, Cambridge, UK

NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics | Pharmtech Focus

NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics

PhoreMost and POLARISqb Announce a Multi-target Collaboration to Investigate Next-generation Cancer Therapies | Pharmtech Focus

PhoreMost and POLARISqb Announce a Multi-target Collaboration to Investigate Next-generation Cancer Therapies